STOCK TITAN

[Form 4] Zai Lab Limited American Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Zai Lab CFO Chen Yajing reported multiple transactions on Form 4 involving American Depositary Shares (ADS) on June 25-26, 2025:

  • Acquired 6,250 ADSs through the vesting of Restricted Share Units (RSUs) on June 25
  • Subsequently sold 2,675 ADSs at $36.132 per share on June 26 for tax coverage
  • Following these transactions, directly owns 21,004 ADSs

The RSUs were granted under a four-year vesting schedule beginning June 25, 2023, with equal annual installments. Each ADS represents ten ordinary shares of the company. The automatic sale of shares was specifically conducted to cover tax obligations from the RSU vesting. The transactions were reported through an attorney-in-fact on June 27, 2025.

Chen Yajing, CFO di Zai Lab, ha segnalato più operazioni sul Modulo 4 riguardanti American Depositary Shares (ADS) nei giorni 25-26 giugno 2025:

  • Ha acquisito 6.250 ADS tramite il consolidamento di Restricted Share Units (RSU) il 25 giugno
  • Successivamente ha venduto 2.675 ADS a 36,132 $ per azione il 26 giugno per coprire le tasse
  • Dopo queste operazioni, possiede direttamente 21.004 ADS

Le RSU sono state concesse con un piano di maturazione quadriennale iniziato il 25 giugno 2023, con rate annuali uguali. Ogni ADS rappresenta dieci azioni ordinarie della società. La vendita automatica delle azioni è stata effettuata specificamente per coprire gli obblighi fiscali derivanti dalla maturazione delle RSU. Le operazioni sono state riportate tramite un procuratore il 27 giugno 2025.

Chen Yajing, CFO de Zai Lab, informó múltiples transacciones en el Formulario 4 relacionadas con American Depositary Shares (ADS) los días 25 y 26 de junio de 2025:

  • Adquirió 6,250 ADS mediante la consolidación de Restricted Share Units (RSU) el 25 de junio
  • Posteriormente vendió 2,675 ADS a $36.132 por acción el 26 de junio para cubrir impuestos
  • Tras estas transacciones, posee directamente 21,004 ADS

Las RSU fueron otorgadas bajo un plan de consolidación de cuatro años que comenzó el 25 de junio de 2023, con cuotas anuales iguales. Cada ADS representa diez acciones ordinarias de la compañía. La venta automática de acciones se realizó específicamente para cubrir obligaciones fiscales derivadas de la consolidación de las RSU. Las transacciones fueron reportadas por un apoderado el 27 de junio de 2025.

Zai Lab CFO Chen Yajing는 2025년 6월 25일부터 26일까지 미국예탁증서(ADS)와 관련된 여러 거래를 Form 4에 보고했습니다:

  • 2025년 6월 25일 제한 주식 단위(RSU)의 권리 확정으로 6,250 ADS를 취득함
  • 이후 6월 26일 주당 $36.1322,675 ADS를 세금 납부를 위해 매도함
  • 이 거래 후 직접 보유한 ADS는 21,004 ADS

RSU는 2023년 6월 25일부터 시작되는 4년간의 권리 확정 일정에 따라 매년 동일한 비율로 부여되었습니다. 각 ADS는 회사의 보통주 10주를 나타냅니다. 주식 자동 매도는 RSU 권리 확정에 따른 세금 납부를 위해 특별히 진행되었습니다. 거래는 2025년 6월 27일 대리인을 통해 보고되었습니다.

Chen Yajing, CFO de Zai Lab, a déclaré plusieurs transactions sur le formulaire 4 concernant des American Depositary Shares (ADS) les 25 et 26 juin 2025 :

  • A acquis 6 250 ADS grâce à la levée des Restricted Share Units (RSU) le 25 juin
  • Vendu ensuite 2 675 ADS au prix de 36,132 $ par action le 26 juin pour couvrir les impôts
  • Après ces opérations, détient directement 21 004 ADS

Les RSU ont été attribuées selon un calendrier d'acquisition de quatre ans débutant le 25 juin 2023, avec des versements annuels égaux. Chaque ADS représente dix actions ordinaires de la société. La vente automatique des actions a été réalisée spécifiquement pour couvrir les obligations fiscales liées à l'acquisition des RSU. Les transactions ont été déclarées par un mandataire le 27 juin 2025.

Zai Lab CFO Chen Yajing meldete mehrere Transaktionen im Formular 4, die sich am 25. und 26. Juni 2025 auf American Depositary Shares (ADS) beziehen:

  • Am 25. Juni wurden 6.250 ADS durch die Vesting von Restricted Share Units (RSUs) erworben
  • Am 26. Juni wurden anschließend 2.675 ADS zum Preis von 36,132 $ pro Aktie verkauft, um Steuern zu decken
  • Nach diesen Transaktionen besitzt er direkt 21.004 ADS

Die RSUs wurden im Rahmen eines vierjährigen Vestingplans ab dem 25. Juni 2023 mit gleichen jährlichen Raten gewährt. Jede ADS entspricht zehn Stammaktien des Unternehmens. Der automatische Verkauf der Aktien erfolgte speziell zur Deckung der Steuerverpflichtungen aus dem Vesting der RSUs. Die Transaktionen wurden am 27. Juni 2025 über einen Bevollmächtigten gemeldet.

Positive
  • None.
Negative
  • None.

Chen Yajing, CFO di Zai Lab, ha segnalato più operazioni sul Modulo 4 riguardanti American Depositary Shares (ADS) nei giorni 25-26 giugno 2025:

  • Ha acquisito 6.250 ADS tramite il consolidamento di Restricted Share Units (RSU) il 25 giugno
  • Successivamente ha venduto 2.675 ADS a 36,132 $ per azione il 26 giugno per coprire le tasse
  • Dopo queste operazioni, possiede direttamente 21.004 ADS

Le RSU sono state concesse con un piano di maturazione quadriennale iniziato il 25 giugno 2023, con rate annuali uguali. Ogni ADS rappresenta dieci azioni ordinarie della società. La vendita automatica delle azioni è stata effettuata specificamente per coprire gli obblighi fiscali derivanti dalla maturazione delle RSU. Le operazioni sono state riportate tramite un procuratore il 27 giugno 2025.

Chen Yajing, CFO de Zai Lab, informó múltiples transacciones en el Formulario 4 relacionadas con American Depositary Shares (ADS) los días 25 y 26 de junio de 2025:

  • Adquirió 6,250 ADS mediante la consolidación de Restricted Share Units (RSU) el 25 de junio
  • Posteriormente vendió 2,675 ADS a $36.132 por acción el 26 de junio para cubrir impuestos
  • Tras estas transacciones, posee directamente 21,004 ADS

Las RSU fueron otorgadas bajo un plan de consolidación de cuatro años que comenzó el 25 de junio de 2023, con cuotas anuales iguales. Cada ADS representa diez acciones ordinarias de la compañía. La venta automática de acciones se realizó específicamente para cubrir obligaciones fiscales derivadas de la consolidación de las RSU. Las transacciones fueron reportadas por un apoderado el 27 de junio de 2025.

Zai Lab CFO Chen Yajing는 2025년 6월 25일부터 26일까지 미국예탁증서(ADS)와 관련된 여러 거래를 Form 4에 보고했습니다:

  • 2025년 6월 25일 제한 주식 단위(RSU)의 권리 확정으로 6,250 ADS를 취득함
  • 이후 6월 26일 주당 $36.1322,675 ADS를 세금 납부를 위해 매도함
  • 이 거래 후 직접 보유한 ADS는 21,004 ADS

RSU는 2023년 6월 25일부터 시작되는 4년간의 권리 확정 일정에 따라 매년 동일한 비율로 부여되었습니다. 각 ADS는 회사의 보통주 10주를 나타냅니다. 주식 자동 매도는 RSU 권리 확정에 따른 세금 납부를 위해 특별히 진행되었습니다. 거래는 2025년 6월 27일 대리인을 통해 보고되었습니다.

Chen Yajing, CFO de Zai Lab, a déclaré plusieurs transactions sur le formulaire 4 concernant des American Depositary Shares (ADS) les 25 et 26 juin 2025 :

  • A acquis 6 250 ADS grâce à la levée des Restricted Share Units (RSU) le 25 juin
  • Vendu ensuite 2 675 ADS au prix de 36,132 $ par action le 26 juin pour couvrir les impôts
  • Après ces opérations, détient directement 21 004 ADS

Les RSU ont été attribuées selon un calendrier d'acquisition de quatre ans débutant le 25 juin 2023, avec des versements annuels égaux. Chaque ADS représente dix actions ordinaires de la société. La vente automatique des actions a été réalisée spécifiquement pour couvrir les obligations fiscales liées à l'acquisition des RSU. Les transactions ont été déclarées par un mandataire le 27 juin 2025.

Zai Lab CFO Chen Yajing meldete mehrere Transaktionen im Formular 4, die sich am 25. und 26. Juni 2025 auf American Depositary Shares (ADS) beziehen:

  • Am 25. Juni wurden 6.250 ADS durch die Vesting von Restricted Share Units (RSUs) erworben
  • Am 26. Juni wurden anschließend 2.675 ADS zum Preis von 36,132 $ pro Aktie verkauft, um Steuern zu decken
  • Nach diesen Transaktionen besitzt er direkt 21.004 ADS

Die RSUs wurden im Rahmen eines vierjährigen Vestingplans ab dem 25. Juni 2023 mit gleichen jährlichen Raten gewährt. Jede ADS entspricht zehn Stammaktien des Unternehmens. Der automatische Verkauf der Aktien erfolgte speziell zur Deckung der Steuerverpflichtungen aus dem Vesting der RSUs. Die Transaktionen wurden am 27. Juni 2025 über einen Bevollmächtigten gemeldet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Chen Yajing

(Last) (First) (Middle)
C/O ZAI LAB LIMITED
314 MAIN STREET, 4TH FLOOR, SUITE 100

(Street)
CAMBRIDGE MA 02142

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Zai Lab Ltd [ ZLAB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
06/25/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
American Depositary Shares(1) 06/25/2025 M 6,250(2) A (3) 23,679 D
American Depositary Shares(1) 06/26/2025 S 2,675(4) D $36.132 21,004 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Share Units (3) 06/25/2025 M 6,250 (5) (5) American Depositary Shares(1) 6,250 $0 6,250 D
Explanation of Responses:
1. Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
2. ADSs acquired upon vesting of Restricted Share Units ("RSUs").
3. Each RSU represents a contingent right to receive one ADS.
4. These ADSs were sold automatically to cover taxes upon vesting of RSUs.
5. The RSUs vest in equal annual installments over four years beginning on 06/25/2023, the first anniversary of the date of grant. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.
/s/ Bruce Blefeld, Attorney-in-Fact 06/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many ZLAB shares did CFO Chen Yajing sell on June 26, 2025?

CFO Chen Yajing sold 2,675 American Depositary Shares (ADS) of ZLAB on June 26, 2025 at a price of $36.132 per share. This sale was made automatically to cover taxes upon the vesting of Restricted Share Units (RSUs).

What was the vesting schedule for ZLAB CFO Chen Yajing's Restricted Share Units?

The Restricted Share Units (RSUs) vest in equal annual installments over four years, with vesting beginning on June 25, 2023, which was the first anniversary of the grant date. Upon vesting, the shares are delivered to the reporting person in the form of American Depositary Shares (ADSs).

How many ZLAB American Depositary Shares does Chen Yajing own after the reported transactions?

Following the reported transactions, Chen Yajing directly owns 21,004 American Depositary Shares (ADS) of ZLAB. This amount reflects the acquisition of 6,250 shares from vested RSUs and the subsequent sale of 2,675 shares for tax purposes.

What is the conversion ratio of ZLAB's American Depositary Shares to Ordinary Shares?

Each ZLAB American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. The filing notes that the ADSs and Ordinary Shares are fully fungible.
Zai Lab Limited

NASDAQ:ZLAB

ZLAB Rankings

ZLAB Latest News

ZLAB Latest SEC Filings

ZLAB Stock Data

3.96B
106.54M
1.42%
50.94%
3.61%
Biotechnology
Pharmaceutical Preparations
Link
China
SHANGHAI